Meeting highlights: the first korean breast cancer treatment consensus conference. - Wikidata - wikimedia - TriplyDB

Meeting highlights: the first korean breast cancer treatment consensus conference.

Meeting highlights: the first korean breast cancer treatment consensus conference.

http://www.wikidata.org/entity/Q34779593

about

Risk Factors Associated with Discordant Ki-67 Levels between Preoperative Biopsy and Postoperative Surgical Specimens in Breast Cancers Meeting Highlights: The Second Consensus Conference for Breast Cancer Treatment in Korea

P2860

Q35949292-CB798A00-AAA1-4792-8E57-4A0EC44E4DF3 Q42008509-75C583EC-DFF6-4773-9094-3531BFD5F3B0

P2860

Meeting highlights: the first korean breast cancer treatment consensus conference.

http://www.wikidata.org/entity/Q34779593

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Meeting highlights: the first korean breast cancer treatment consensus conference.

@ast

Meeting highlights: the first korean breast cancer treatment consensus conference.

@en

Meeting highlights: the first korean breast cancer treatment consensus conference.

@nl

type

label

Meeting highlights: the first korean breast cancer treatment consensus conference.

@ast

Meeting highlights: the first korean breast cancer treatment consensus conference.

@en

Meeting highlights: the first korean breast cancer treatment consensus conference.

@nl

prefLabel

Meeting highlights: the first korean breast cancer treatment consensus conference.

@ast

Meeting highlights: the first korean breast cancer treatment consensus conference.

@en

Meeting highlights: the first korean breast cancer treatment consensus conference.

@nl

P1433

Q34779593-18E3A4F3-3256-4D38-9F64-7F7C307B1CCB

P1476

Q34779593-AFD229C7-FD13-4FFD-AC9E-D71DEEE58A0A

P2093

Q34779593-0FA9ECB6-D5FE-41F6-818E-656DB4B164CE

Q34779593-1CB53C47-5CFC-4DBE-8BFA-3FF2000F3F2B

Q34779593-28503BBA-FFB8-439F-82DB-E48155A0B7B3

Q34779593-2E5063FC-DE3A-45D7-A16F-1BF3EF5A8125

Q34779593-3281E7A1-84C7-41B0-B6CE-16738C04A98B

Q34779593-464D3EEE-BE47-4684-A567-D2B21515B4A5

Q34779593-65D7520E-1EB9-403F-9E9F-E6780505C6AB

Q34779593-C894067D-6CED-452C-A7AB-3EC78A6CD772

Q34779593-F155A465-757E-4E13-9A25-3D1127B3BE91

P2860

Q34779593-055396E6-A3BD-4E41-AD6A-F228F33DEBCD

Q34779593-0F819951-B6A6-4270-A996-F207DC6E7942

Q34779593-1812B12D-568B-4775-8AF7-AB8FE30F4B1C

Q34779593-2204BE42-D63D-4F8B-8FD3-FC72BC9483C0

Q34779593-223F7EB2-6A1C-4182-9E85-E9BD29055008

Q34779593-24AFA560-EF24-48BC-BF42-50F05517E1C9

Q34779593-2F37D9CC-B08D-455B-A684-C68FD28009CA

Q34779593-36059FD3-C838-4521-B293-E96CA6EE9A9C

Q34779593-4043E04E-ED26-4A97-A7F4-3FCED41E2779

Q34779593-4E9D5F6B-D026-488D-A718-9AF7301919D7

P304

Q34779593-6E0C9C72-2081-4789-AB9D-B59FBF12DAFE

P31

Q34779593-E1FF5794-FA23-4621-BD91-98AAB984823F

P356

Q34779593-DBBFB3B2-ACFD-4779-AB9E-A4AE995E8B9A

P433

Q34779593-0B052D42-34C6-4B02-BA47-B83BF5C76C6B

P478

Q34779593-32DE93F4-8F2C-4182-99F7-7D108C4CDC93

P577

Q34779593-151AB461-3074-4359-8B4F-44434E5BB26B

P5875

Q34779593-CCE0D063-F740-4277-9EF9-23614F6CF21D

P698

Q34779593-56358C51-1DE6-4507-8ADD-DB7F59686137

P932

Q34779593-E6A06866-5609-4748-8CAB-80DA4AD5B1D5

P356

JBC.2014.17.4.308

P1433

Journal of breast cancer

P1476

Meeting highlights: the first korean breast cancer treatment consensus conference.

@en

P2093

Airi Han

http://www.w3.org/2001/XMLSchema#string

Byung-Ho Son

http://www.w3.org/2001/XMLSchema#string

Hae Kyung Lee

http://www.w3.org/2001/XMLSchema#string

Jeryoung Kim

http://www.w3.org/2001/XMLSchema#string

Korean Breast Cancer Treatment Consensus Conference Panelists

http://www.w3.org/2001/XMLSchema#string

Kyoung Eun Lee

http://www.w3.org/2001/XMLSchema#string

Kyung Hae Jung

http://www.w3.org/2001/XMLSchema#string

Sung-Won Kim

http://www.w3.org/2001/XMLSchema#string

Yeon Hee Park

http://www.w3.org/2001/XMLSchema#string

P2860

Breast cancer risk accumulation starts early: prevention must also

Trastuzumab emtansine for HER2-positive advanced breast cancer.

Randomised trials in surgery: problems and possible solutions.

Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study.

The basic facts of korean breast cancer in 2011: results of a nationwide survey and breast cancer registry database.

Lapatinib plus capecitabine in women with HER-2-positive advanced breast cancer: final survival analysis of a phase III randomized trial

Changing patterns in the clinical characteristics of korean breast cancer from 1996-2010 using an online nationwide breast cancer database

Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343

Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial

P304

308-313

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4048/JBC.2014.17.4.308

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2014-12-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

270291167

http://www.w3.org/2001/XMLSchema#string

P698

25548577

http://www.w3.org/2001/XMLSchema#string

P932

4278048

http://www.w3.org/2001/XMLSchema#string